Overview
This course is designed to provide a firm grounding in key aspects of European Clinical Pre- and Post-Marketing Safety regulatory requirements. This five-day training course also includes highlights and updates on the pharmacovigilance legislation and the latest news on the international harmonisation and standardisation activities in pharmacovigilance.
"The course provides a great insight to the different areas in pharmacovigilance. Case studies force each and everyone to really think the matters discussed. Also a great chance to build international network with colleagues from other companies."
Antti Matias Miikki, Pharmacovigilance Specialist, Santen Oy
"I would recommend it to anyone working in pharmacovigilance for at least 1 year. The course gives the perfect overview, and practical advice."
Katarína Lihocká, Pharmacovigilance Specialist, European Pharminvent Services
Program Committee
-
Gaby L. Danan, MD, PhD Pharmacovigilance Expert
GLD, France -
Phil Tregunno Deputy Director - Patient Safety Monitoring
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Have an account?